Mechanisms and Clinical Implications of Elevated Trimethylamine N‑oxide (TMAO) Levels

Mechanisms of TMAO Elevation

Elevated TMAO concentrations arise from three primary mechanisms: (1) dietary intake of TMAO precursors such as L‑carnitine and phosphatidylcholine found in red meat, eggs, and full‑fat dairy; (2) direct ingestion of TMAO‑rich foods (e.g., certain fish and seafood); and (3) reduced renal clearance in kidney disease. 1, 2

Animal‑based foods – Red meat and processed meats are rich in L‑carnitine and phosphatidylcholine; gut microbes convert these precursors to trimethylamine (TMA), which is subsequently oxidized by hepatic flavin‑containing monooxygenases (FMOs) to TMAO. 1, 2
Proteolytic fermentation – Fermentation of animal proteins by gut bacteria generates TMA as an intermediate metabolite, providing a substrate for hepatic conversion to TMAO. 2, 3

Hepatic FMOs, particularly the isoform FMO3, catalyze the oxidation of gut‑derived TMA to TMAO, representing the key enzymatic step in systemic TMAO production. 1, 2
Consumption of cruciferous vegetables may inhibit FMO3 activity, potentially attenuating the conversion of TMA to TMAO and lowering circulating levels. 2

Under normal physiology, the kidneys efficiently excrete TMAO; however, plasma TMAO concentrations are markedly elevated in patients with chronic kidney disease, reflecting impaired clearance. 1
In clinical populations, reduced kidney function is a major confounder of circulating TMAO levels, often outweighing the impact of dietary intake alone. 1, 2

Epidemiological studies consistently demonstrate that regular consumption of fatty fish—despite its high TMAO content—associates with favorable cardiometabolic outcomes, indicating that fish‑derived TMAO does not translate into increased cardiovascular risk. 1, 2

The American Heart Association acknowledges the paradox that concerns about TMAO from fish are not supported by the large body of evidence showing cardiovascular benefits from seafood consumption 4, 5, 6
TMAO is produced when gut microbiota convert L-carnitine and phosphatidylcholine into trimethylamine, which is then oxidized by hepatic enzymes to TMAO 7
The TMAO paradigm does not align with epidemiological findings showing that fatty fish—which is rich in TMAO and its precursors—is associated with beneficial cardiometabolic outcomes 7

The American Heart Association recommends consuming nonfried seafood, especially species higher in omega-3 fatty acids, 1-2 times per week for cardiovascular benefits, including reduced risk of cardiac death, coronary heart disease, and ischemic stroke 4, 5, 6
Red meat and processed meats should be limited because proteolytic fermentation produces not only TMAO but also other detrimental metabolites including ammonia, p-cresol, and hydrogen sulfide 7
High-fat dairy, eggs, and foods rich in L-carnitine and phosphatidylcholine should be consumed in moderation 7, 8
Cruciferous vegetables can inhibit FMO3 activity, potentially reducing TMAO production 7
Polyphenol-rich foods have anti-inflammatory and antioxidant properties that may counteract TMAO-related cardiovascular effects 8

Enteral administration of betaine may be converted into methylamine-N-oxide by gut microflora and subsequently metabolized into TMAO, potentially having negative long-term cardiovascular impact 9
The upper limit for betaine in adults is 3.5 g/day, and for choline supplementation during pregnancy is also 3.5 g/day 9, 10
Betaine is used as adjunct treatment for homocystinuria and may be beneficial when methylation processes are impaired, such as in MTHFR 677TT genotype 9